The toxic debate about obesity rages on. But at least we know if Mounjaro or Wegovy is better for weight loss | Zoe Williams
Guardian2 days
Mounjaro Outperforms Wegovy in Weight Loss Drug Trial
Above: Slimming syringes of the brands "Wegovy", "Ozempic," and "Mounjaro" are sold in the Achat pharmacy in Mitte, Berlin, Germany, on July 11, 2024. Image copyright: Jens Kalaene/Contributor/picture alliance via Getty Images
The Spin
Pro-establishment narrative
Weight loss drugs have made historic leaps and bounds in the fight to end obesity, now rivaling surgery's impact. While Mounjaro leads with 25% weight loss, Wegovy's 14% reduction is no small feat either. That said, side effects like nausea and muscle loss highlight risks. Ongoing research is vital to ensure these miracle drugs are as safe as possible, cementing their revolutionary role in tackling the global obesity crisis.
Establishment-critical narrative
Mounjaro and Wegovy are certainly groundbreaking for obesity, but will never be cures. Not only do they contain side effects like nausea and muscle loss, but they dodge the real issue: a food system pushing processed junk. Natural, whole foods can keep everyone in better shape, especially those genetically prone to obesity. Of course, research must continue to refine drug safety, but diet reform will always trump pharmaceutical fixes.